Global law firm that serves the world's most innovative people and businesses

Labeling AI-Generated Content – Implementing the Transparency Requirements of the AI Regulation in the Automotive Sector

by Thomas Kahl and Nils von Reith

Taylor Wessing advises the founders and management team of TERRAS Group on H.I.G. Capital’s acquisition of a majority stake

by multiple authors

The UPC’s first referral to the European Court of Justice: Cross-border preliminary injunctions against intermediaries and non-UPC defendants

by multiple authors

Taylor Wessing advises co-lead investor East X Ventures on Proxima Fusion's € 411 million Series A-2 financing round

by multiple authors

Taylor Wessing is advising around 400 holiday property owners in the proceedings concerning the OstseeResort Olpenitz

by multiple authors

Hungarian supreme court on legal standing to challenge generic marketing authorisations

Case law – Hungarian Supreme Court (Kúria), precedent-setting judgment of 7 May 2026 – Kfv.37.810/2025/27 – On legal standing to challenge generic marketing authorisations

by Fruzsina Kónya

8 of 9 Insights

Taylor Wessing Advises Trivium eSolutions on the Launch of a Software-Engineering Platform with NetRom Software and Investcorp

by multiple authors

Case law – VfGH on the eImpfpass and central vaccination register

The Austrian Constitutional Court rejected challenges to the eImpfpass and central vaccination register on procedural grounds. The decision leaves the register in place, but highlights the role of data protection remedies in digital health infrastructure.

by Christopher Bakier

6 of 9 Insights

The new Product Liability Directive: three life sciences priorities before the 2026 deadline

The new EU Product Liability Directive applies to products placed on the market after 9 December 2026. Three changes call for decisions by life sciences companies now: software and AI as products, an eased burden of proof, and disclosure of internal evidence.

by Bartosz Świdrak

3 of 9 Insights

Update: AI-Enabled Medical Devices and IVDs Confirmed as “High-Risk”

Digital Omnibus Update. More time (up to August 2028) yet confirming that AI-enabled medical devices and IVDs stay subject to the AI Act.

by Irina Rebin

4 of 9 Insights

Poland’s new AI systems act: a regulator and practical tools

Poland’s new AI systems act builds the national framework for the EU AI Act. A new regulator is introduced, alongside two practical tools.

by Bartosz Świdrak

9 of 9 Insights

Medical Cannabis Platforms Breach Advertising Ban

Case law – German Federal Court of Justice (Bundesgerichtshof) – Online platforms brokering medical cannabis treatments breach the prohibition of public advertising under the German Healthcare Advertising Act

by Irina Rebin

7 of 9 Insights